Objective: Evaluate the clinical and prognostic factors affecting the survival of breast cancer patients with hormone receptor-negative. Methods: Retrospective study on 141 breast cancer patients with hormone receptor-negative, stage II - III, radical treatment, follow-up for the long term survival. Results: Overall survival and disease-free survival after 5 years was 75.2 percent, 68 percent, respectively. A number of factors affect survival after treatment. Status of lymph node metastasis and the number of axillary lymph node metastases most affected: The number of axillary lymph node metastases significantly impact on survival. The overall survival is inversely proportional to the number of ,axillary lymph node metastases. No axillary lymph node metastasis 90.6 percent of survival that was more farvoral as compared to patients with 4 axillary lymph nodes metastases 39.3 percent. Adjuvant chemotherapy had a role to improve survival of this patient group. Conclusion: Survival after treatment depends on both prognostic factors and complementary therapies.